Proceedings from a CME symposium held during the IASLC 2019
North America Conference on Lung Cancer. Featuring perspectives
from moderator Dr Joel W Neal and faculty members Drs Nasser H
Hanna, Leora Horn and Lecia V Sequist:
Introduction (00:00)
Evolving Therapeutic Algorithms in Small Cell Lung Cancer
(SCLC) (1:04)
Optimal Therapeutic Approaches for Patients with Metastatic
Non-Small Cell Lung Cancer (NSCLC) and EGFR Tumor Mutations
(21:55)
Management of NSCLC with ALK Rearrangements (35:24)
Current and Future Role of Existing and Emerging ROS1
Inhibitors (45:16)
Treatment of Metastatic NSCLC with Other Targetable Tumor
Mutations (56:06)
Role of Anti-PD-1/PD-L1 Antibodies Alone or in Combination with
Other Systemic Therapies for Metastatic NSCLC (1:15:41)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.